Zobrazeno 1 - 10
of 65
pro vyhledávání: '"Maria Simona, Pino"'
Autor:
Matteo Fassan, Fotios Loupakis, Vittorina Zagonel, Francesca Bergamo, Maurizio Martini, Giovanna De Maglio, Angelo Paolo Dei Tos, Giovanni Lanza, Luca Reggiani Bonetti, Stefano Lazzi, Claudia Mescoli, Massimo Rugge, Gabriella Fontanini, Serena Saggio, Umberto Malapelle, Giada Munari, Armando Orlandi, Stefano Cascinu, Fabio Gelsomino, Filippo Pietrantonio, Salvatore Corallo, Chiara Cremolini, Carlotta Antoniotti, Federica Urbano, Maria Simona Pino, Nicoletta Pella, Sara Lonardi, Paola Biason, Marta Schirripa
Supplementary Figure S2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b54a4eb9c4e1e122424feeea60a9280
https://doi.org/10.1158/1078-0432.22471353.v1
https://doi.org/10.1158/1078-0432.22471353.v1
Autor:
Matteo Fassan, Fotios Loupakis, Vittorina Zagonel, Francesca Bergamo, Maurizio Martini, Giovanna De Maglio, Angelo Paolo Dei Tos, Giovanni Lanza, Luca Reggiani Bonetti, Stefano Lazzi, Claudia Mescoli, Massimo Rugge, Gabriella Fontanini, Serena Saggio, Umberto Malapelle, Giada Munari, Armando Orlandi, Stefano Cascinu, Fabio Gelsomino, Filippo Pietrantonio, Salvatore Corallo, Chiara Cremolini, Carlotta Antoniotti, Federica Urbano, Maria Simona Pino, Nicoletta Pella, Sara Lonardi, Paola Biason, Marta Schirripa
Purpose:BRAF mutations are grouped in activating RAS-independent signaling as monomers (class 1–V600E) or as dimers (class 2–codons 597/601), and RAS-dependent with impaired kinase activity (class 3–codons 594/596). Although clinical, pathologi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f675d19d13132b5c76db9c0557d4bc0
https://doi.org/10.1158/1078-0432.c.6527859.v1
https://doi.org/10.1158/1078-0432.c.6527859.v1
Autor:
Matteo Fassan, Fotios Loupakis, Vittorina Zagonel, Francesca Bergamo, Maurizio Martini, Giovanna De Maglio, Angelo Paolo Dei Tos, Giovanni Lanza, Luca Reggiani Bonetti, Stefano Lazzi, Claudia Mescoli, Massimo Rugge, Gabriella Fontanini, Serena Saggio, Umberto Malapelle, Giada Munari, Armando Orlandi, Stefano Cascinu, Fabio Gelsomino, Filippo Pietrantonio, Salvatore Corallo, Chiara Cremolini, Carlotta Antoniotti, Federica Urbano, Maria Simona Pino, Nicoletta Pella, Sara Lonardi, Paola Biason, Marta Schirripa
Supplementary Table
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abac93d6119545de704e86ec9b8708b1
https://doi.org/10.1158/1078-0432.22471347
https://doi.org/10.1158/1078-0432.22471347
Autor:
R. Barca, S. Fondelli, Maria Simona Pino, P. Alpi, L. Paoletti, Andrea Bassetti, M. Perna, Serenella Russo, Barbara Grilli Leonulli, Luisa Fioretto, Camilla Delli Paoli, Francesca Martella, Silvia Scoccianti, Saverio Caini, Federica Furlan
Publikováno v:
The Lancet. Oncology
Lancet Oncology, The - Sous presse. Epreuves corrigees par l'auteur. Disponible en ligne depuis le mercredi 11 aout 2021
Autor:
Nicola Pimpinelli, Lorenzo Borgognoni, Serena Sestini, Eleonora Campolmi, Isabella Ciardetti, Raffaella Grifoni, Lucia Caligiani, Maria Simona Pino, Bernardo Carli
Publikováno v:
Italian Journal of Dermatology and Venereology. 157
Background The aim of the study is to highlight the psychological aspects involved in patients with advanced melanoma and to describe the differences between subjects who are positive and negative for the BRAFv600e genetic mutation, a variable that l
Autor:
Giovanni Luca Ceresoli, Concetta Sergi, Diego Cortinovis, Silvia Novello, Annamaria Carta, G. Romano, Silvia Ferrari, Giovanna Finocchiaro, Alessandro Zullo, Maria Simona Pino, Rita Chiari, Domenico Galetta, Fabiana Vitiello, Giuseppe Tonini, Francesco Verderame, Vieri Scotti, Alessandro Del Conte, Maria Pagano, Antonio Rossi, Fausto Barbieri, Daniela Nonnis, Pier Luigi Piovano, Gloria Borra, Maria Lucia Reale, Maria Rita Migliorino, Rossana Berardi, Marcello Tiseo, Alain Gelibter, Emanuela Vattemi, Fabiana Letizia Cecere, Olga Martelli
Objectives Molecular diagnostics and care of non-small cell lung cancer (NSCLC) are continuously evolving. Few data document the current strategies to manage advanced NSCLC patients beyond progression in clinical practice. Patients and methods Be-Tea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6eb27df8205eed0d6825639d805ec39
http://hdl.handle.net/2318/1732911
http://hdl.handle.net/2318/1732911
Publikováno v:
Frontiers in Endocrinology, Vol 3 (2012)
Prostate cancer (PC) is the leading cause of cancer and the second leading cause of cancer-death among men in the Western world. About 10%-20% of men with PC present with metastatic disease at diagnosis, while 20%-30% of patients diagnosed with local
Externí odkaz:
https://doaj.org/article/d0bf527874564693bf07a1dd76c26144
Autor:
Marta, Schirripa, Paola, Biason, Sara, Lonardi, Nicoletta, Pella, Maria Simona, Pino, Federica, Urbano, Carlotta, Antoniotti, Chiara, Cremolini, Salvatore, Corallo, Filippo, Pietrantonio, Fabio, Gelsomino, Stefano, Cascinu, Armando, Orlandi, Giada, Munari, Umberto, Malapelle, Serena, Saggio, Gabriella, Fontanini, Massimo, Rugge, Claudia, Mescoli, Stefano, Lazzi, Luca, Reggiani Bonetti, Giovanni, Lanza, Angelo Paolo, Dei Tos, Giovanna, De Maglio, Maurizio, Martini, Francesca, Bergamo, Vittorina, Zagonel, Fotios, Loupakis, Matteo, Fassan
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 25(13)
Data from 117 patients withClass 3For the first time, different clinical and pathologic features and outcome data were reported according to the three
Autor:
Raffaella Bertè, Martina Valgiusti, Silvia Quadrini, Emanuela Scarpi, Elena Orlandi, Monia Dall'Agata, Alberto Farolfi, Andrea Casadei Gardini, Vittorina Zagonel, Ferdinando Garetto, Oriana Nanni, Marco Maltoni, Elena Amaducci, Chiara Broglia, Teresa Gamucci, Sara Alquati, Elisabetta Sansoni, Silvia Ruscelli, Romina Rossi, Daris Ferrari, Maria Simona Pino, Filomena Narducci, Silvia Stragliotto, Stefania Schiavon, Roberto Bortolussi, F. Negri
Purpose: Early palliative care (EPC) has shown a positive impact on quality of life (QoL), quality of care, and healthcare costs. We evaluated such effects in patients with advanced gastric cancer. Methods: In this prospective, multicenter study, 186
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48603cb310ba8e447a36df1898b1722e
Autor:
Armando Orlandi, Nicoletta Pella, Giada Munari, Claudia Mescoli, Vittorina Zagonel, Umberto Malapelle, Maurizio Martini, Fotios Loupakis, Stefano Cascinu, Francesca Bergamo, Federica Urbano, Giovanna De Maglio, Marta Schirripa, Sara Lonardi, Salvatore Corallo, Massimo Rugge, Paola Biason, Angelo Paolo Dei Tos, Carlotta Antoniotti, Luca Reggiani Bonetti, Chiara Cremolini, Fabio Gelsomino, Gabriella Fontanini, Matteo Fassan, Maria Simona Pino, Giovanni Lanza, Filippo Pietrantonio, Stefano Lazzi, Serena Saggio
Purpose: BRAF mutations are grouped in activating RAS-independent signaling as monomers (class 1–V600E) or as dimers (class 2–codons 597/601), and RAS-dependent with impaired kinase activity (class 3–codons 594/596). Although clinical, patholog
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84794ca65527668f8b5d6fb5fa91e958